Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |